Reduced pregnane neurosteroids such as allopregnanolone and pregnanolone ar
e potent neuromodulators able to affect a number of membrane receptors, inc
luding gamma -aminobutyric acid (GABA)(A), N-methyl-D-aspartate (NMDA), 5-h
ydroxytryptamine (5-HT)(3), and sigma (1) receptors. The present study used
a drug discrimination procedure to assess further the receptor effects of
pregnanolone in vivo. Rats were trained to discriminate 5 mg/kg pregnanolon
e from saline in a two-lever operant task maintained by food reinforcement.
The opiate agonist morphine and the negative GABAA modulator dehydroepiand
rosterone sulfate did not substitute for pregnanolone. All of the GABAA pos
itive modulators tested (allopregnanolone, epipregnanolone, androsterone, p
entobarbital, midazolam, and zolpidem) dose dependently substituted for pre
gnanolone. The direct GABA-site agonists 4,5,6,7-tetrahydroisoxazolo[4,5-c]
pyridin-3-ol and muscimol failed to substitute for pregnanolone. Ethanol a
nd the sigma (1) receptor agonist SKF 10047 fully substituted for pregnanol
one, and the NMDA antagonist MK-801 partially substituted for pregnanolone.
The 5-HT3 antagonist tropisetron did not substitute at any dose tested. Th
e 5-HT3 agonist SR 57227A reached full substitution, whereas the other 5-HT
3 agonist tested, m-chlorophenylbiguanide, produced partial substitution. T
hese results suggest that positive GABA(A) modulation, but not direct agoni
sm, confers a discriminative stimulus effect similar to pregnanolone. Addit
ionally, antagonism of NMDA receptors and activation of 5-HT3 and sigma (1)
receptors modulate stimulus effects similar to the pregnanolone cue. Overa
ll, the data suggest that pregnanolone produces discriminative stimulus eff
ects representative of a wide-spectrum sedative hypnotic.